Mallory Morales - 13 Jun 2023 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
VICE PRESIDENT, FINANCE
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Mallory Morales
Issuer symbol
IMRX
Transactions as of
13 Jun 2023
Net transactions value
$0
Form type
4
Filing time
14 Jun 2023, 16:15:00 UTC
Previous filing
17 Feb 2023
Next filing
09 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +15,000 $0.000000 15,000 13 Jun 2023 Class A Common Stock 15,000 $9.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable (subject to continued service to the Issuer through the applicable vesting date) in forty-eight (48) substantially equal monthly installments following the vesting commencement date of July 1, 2023, and will be fully vested and exercisable on July 1, 2027.